| Literature DB >> 16786237 |
Burcu Demirkan1, Yesim Guray, Umit Guray, Sule Korkmaz.
Abstract
Although the glycoprotein IIb/IIIa receptor inhibitors have improved outcomes of patients with acute coronary syndrome (ACS), therapy with these agents may cause thrombocytopenia with bleeding complications. This adverse effect is seemed to be rare with tirofiban. In this report, we describe a case of acute profound thrombocytopenia within two hours of tirofiban administration and review the differential diagnosis and the management of thrombocytopenia.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16786237 DOI： 10.1007/s11239-006-7789-1
Source DB: PubMed Journal: J Thromb Thrombolysis ISSN： 0929-5305 Impact factor: 2.300